Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALIGN TECHNOLOGY INCALGN · Entity 3488 | SVP & Mng Dir Info Tech | February 20, 2020 | February 25, 2020 |
| INTUITIVE SURGICAL INCISRG · Entity 2878 | Director | April 30, 2026 | May 01, 2026 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALIGN TECHNOLOGY INC
Report date February 20, 2020 · Filed February 25, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,972 |
Reported balance
After 2020-02-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-02-20 · Exercise / conversion · Acquired 14,036 · Balance 20,972 F1: Includes 10 shares acquired under the ALGN ESPP on January 31, 2020. |
| Common StockSEC Table I · non-derivative | Direct | 13,409 |
Reported balance
After 2020-02-20 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-02-20 · Tax withholding · Disposed 7,563 · Balance 13,409 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-02-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-02-20 · Exercise / conversion · Disposed 1,902 · Balance 0 F2: Represents par value of ALGN common stock. F3: 1/4th of the restricted stock unit granted on February 20, 2016 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,250 |
Reported balance
After 2020-02-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-02-20 · Exercise / conversion · Disposed 1,250 · Balance 1,250 F2: Represents par value of ALGN common stock. F4: 1/4th of the restricted stock unit granted on February 20, 2017 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. 1/4th of the restricted stock unit will annually and shares will be delivered to reporting person on each vest date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 800 |
Reported balance
After 2020-02-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-02-20 · Exercise / conversion · Disposed 400 · Balance 800 F2: Represents par value of ALGN common stock. F5: 1/4th of the restricted stock unit granted on February 20, 2018 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. 1/4th of the restricted stock unit will annually and shares will be delivered to reporting person on each vest date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,451 |
Reported balance
After 2020-02-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-02-20 · Exercise / conversion · Disposed 484 · Balance 1,451 F2: Represents par value of ALGN common stock. F6: 1/4th of the restricted stock unit granted on February 20, 2019 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. 1/4th of the restricted stock unit will continue to vest annually and shares will be delivered to reporting person on each vest date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,811 |
Reported balance
After 2020-02-20 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-02-20 · Exercise / conversion · Acquired 1,811 · Balance 1,811 F2: Represents par value of ALGN common stock. F8: 1/4th of the restricted stock unit granted on February 20, 2020 will become vested on February 20, 2021 and shares will be delivered to reporting person on such vest date. 1/4th of the restricted stock unit will continue to vest annually and shares will be delivered to reporting person on each vest date. |
| Market Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 10,000 |
Reported balance
After 2020-02-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-02-20 · Exercise / conversion · Disposed 10,000 · Balance 10,000 F2: Represents par value of ALGN common stock. F7: The market stock unit granted on February 20, 2017 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. |
| Market Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 9,193 |
Reported balance
After 2020-02-20 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-02-20 · Exercise / conversion · Acquired 9,193 · Balance 9,193 F2: Represents par value of ALGN common stock. F9: Represents the maximum number of shares which may be issued under the market stock unit. All of the shares which may be issued under the market stock unit will vest on the last day of the third year of the Performance Period (as defined in the market stock unit agreement). |
| Common StockSEC Table I · non-derivative | IndirectHeld jointly with spouse | 1,400 |
Reported balance
Holding disclosure · report date 2020-02-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,400 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 10 shares acquired under the ALGN ESPP on January 31, 2020.
F2: Represents par value of ALGN common stock.
F3: 1/4th of the restricted stock unit granted on February 20, 2016 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date.
F4: 1/4th of the restricted stock unit granted on February 20, 2017 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. 1/4th of the restricted stock unit will annually and shares will be delivered to reporting person on each vest date.
F5: 1/4th of the restricted stock unit granted on February 20, 2018 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. 1/4th of the restricted stock unit will annually and shares will be delivered to reporting person on each vest date.
F6: 1/4th of the restricted stock unit granted on February 20, 2019 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date. 1/4th of the restricted stock unit will continue to vest annually and shares will be delivered to reporting person on each vest date.
F7: The market stock unit granted on February 20, 2017 became vested on February 20, 2020 and shares were delivered to reporting person on such vest date.
F8: 1/4th of the restricted stock unit granted on February 20, 2020 will become vested on February 20, 2021 and shares will be delivered to reporting person on such vest date. 1/4th of the restricted stock unit will continue to vest annually and shares will be delivered to reporting person on each vest date.
F9: Represents the maximum number of shares which may be issued under the market stock unit. All of the shares which may be issued under the market stock unit will vest on the last day of the third year of the Performance Period (as defined in the market stock unit agreement).
INTUITIVE SURGICAL INC
Report date April 30, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,510 |
Reported balance
After 2026-04-30 transaction · row 1
1 source rowRow 1 · 2026-04-30 · Exercise / conversion · Acquired 531 · Balance 1,510 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-04-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-30 · Exercise / conversion · Disposed 531 · Balance 0 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
| Restricted Stock Units - 4-30-2026SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 554 |
Reported balance
After 2026-04-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-30 · Grant · Acquired 554 · Balance 554 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.
ZIMMER BIOMET HOLDINGS, INC.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $89.85 | Direct | 7,033.757 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 173.901 · Balance 7,033.757 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4: Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4: Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2016 Filed Dec 21, 2016 23:46 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Tax withholdingCommon Stock | 796 | $99.39 | $79,114.44 |
DisclosureSEC source: 0001601045-16-000017 · primary_doc.xml · nonDerivative · entry 2 Kolli Sreelakshmi · CIK 0001689392 · VP, Info Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,106 Read SEC document |
| December 20, 2016 Filed Dec 21, 2016 23:46 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001601045-16-000017 · primary_doc.xml · nonDerivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · VP, Info Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.